FES F18 PET/CT

18F-fluoroestradiol (FES) PET/CT · GE Healthcare

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FES F18 PET/CT, covering 2024-07-31 to 2024-07-31. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Utility of FES F18 PET/CT in Metastatic Breast Cancer Patients